Combined endoscopic erbium:YAG laser goniopuncture and cataract surgery

PURPOSE: To study the safety and efficacy of endoscopic erbium:YAG (Er:YAG) laser goniopuncture combined with cataract surgery to treat glaucoma. SETTING: Department of Ophthalmology, Albert-Ludwigs-University Freiburg, Freiburg, Germany, and Institute of Applied Physics, University of Bern, Bern, Switzerland. METHODS: In this nonrandominized clinical trial, 20 eyes of 20 patients with cataract and glaucoma were treated by combined phacoemulsification and Er:YAG goniopuncture. The primary study endpoints were intraocular pressure (IOP), visual acuity, and number of antiglaucoma drugs 1 year after surgery. Two- and 3-year postoperative data were also measured. This prospective treatment arm was compared to a retrospective inclusion-matched control group treated by cataract surgery alone. RESULTS: The mean IOP dropped by 30% (23.5 mm Hg +/- 3.9 [SD] to 16.3 +/- 2.7 mm Hg) after 12 months in the laser-treated group (P<.0001) and by 9% (19.8 +/- 1.3 mm Hg to 18.1 +/- 1.8 mm Hg) in the control group (P =.12). After 3 years, the mean IOP in the laser group was 15.0 +/- 2.0 mm Hg. The mean number of antiglaucoma drugs needed decreased from 1.6 +/- 0.9 to 0.5 +/- 0.8 in the laser group (P<.0001) and from 1.0 +/- 0.9 to 0.8 +/- 0.9 in the control group (P =.21). Anterior chamber hemorrhage occurred in 12 eyes after laser treatment and resolved within 72 hours in all but 1 patient who was on warfarin sodium (Coumadin) therapy. There were no cases of hypotony in either group. CONCLUSIONS: Endoscopic Er:YAG laser goniopuncture was a successful adjunct to cataract surgery in glaucoma patients. Sustained IOP reduction was achieved with few postoperative complications.     

Kombinierte Katarakt- und Glaukomchirurgie

BACKGROUND: The surgical therapy of glaucoma aims at an effective IOP lowering as well as at a long-term effect with few complications. The previous gold standard of combined surgery consisted of cataract surgery and trabeculectomy. The combination of cataract surgery and Erb:YAG goniotomy might be an alternative. METHODS AND PATIENTS: A total of 17 eyes were treated with combined Erb:YAG goniotomy. The control group underwent combined trabeculectomy and consisted of 23 eyes. The mean follow-up was 5 years and assessed IOP lowering, visual acuity, antiglaucomatous drugs, and complications. RESULTS: After 5 years the IOP of the Erb:YAG group decreased from 23.3 to 16.9 mmHg. In the control group, the IOP was reduced from 23.3 mmHg to 15.8 mmHg. Two eyes of the Erb:YAG group needed further surgery due to insufficient IOP control, whereas in the control group ten repeat procedures were necessary. CONCLUSIONS: The small number of complications in combination with a sustainable IOP-lowering effect seems to be an advantage in the long-term treatment of glaucoma. We hope that this can be transferred to the new excimer laser trabeculotomy since the 3-year results are already comparable to the Erb:YAG laser.     

Complications of Neodymium:YAG laser goniopuncture after deep sclerectomy

PURPOSE: To study the complications of Neodymium:YAG (Nd:YAG) goniopuncture after deep sclerectomy with collagen implant (DSCI). METHODS: All patients who underwent a Nd:YAG goniopuncture after a successful DSCI for primary open-angle glaucoma were included in a non-randomized clinical study. RESULTS: Nd:YAG goniopuncture was performed in 31 patients. The mean time from surgery to goniopuncture was 3.2 +/- 3.2 months. The mean intraocular pressure (IOP) before goniopuncture was 32.0 +/- 10.8 mmHg (SD); the mean IOP 1-2 hours after goniopuncture was 16.5 +/- 6.3 mmHg. After a mean follow-up of 5.4 +/- 2.8 months, the mean IOP was 17.8 +/- 11.6 mmHg. Three patients had a spontaneous iris prolapse after Nd:YAG goniopuncture and consequently high IOP. No signs of severe hypotension were observed. CONCLUSION: There are potentially serious complications relating to Nd:YAG goniopuncture after deep sclerectomy. However, further studies are needed to determine the safest time and level of IOP at which to perform Nd:YAG goniopuncture.     

Advanced nonpenetrating trabeculectomy (advanced NPT) and combined surgery of advanced NPT and phacoemulsification and intraocular lens implantation

We have devised a new glaucoma surgery combining deep sclerectomy with nonpenetrating trabeculectomy (NPT); we call this surgery advanced NPT. We evaluated intraocular pressure (IOP) control, postoperative complication and visual acuity after combined advanced NPT and phacoemulsification and intraocular lens implantation (combined surgery), and advanced NPT alone. The mean preoperative IOP for the trabeculectomy only group was 22.4 +/- 6.3 mmHg(bleb+), 23.0 +/- 4.9 mmHg(bleb-), and that of the combined surgery group was 18.1 +/- 4.5 mmHg(bleb+), 18.5 +/- 2.6 mmHg(bleb-). Mean postoperative IOP for the two groups were 13.0 +/- 2.3 mmHg(bleb+), 15.0 +/- 1.5 mmHg(bleb-) and 12.9 +/- 2.7 mmHg(bleb+), 13.3 +/- 2.4 mmHg(bleb-), respectively. After 15 months, the success probability for postoperative IOP control were 63%(bleb+), 23%(bleb-) in the advanced NPT only group (相似文献   

260例青光眼白内障联合手术临床分析

目的：分析评价青光眼白内障联合手术的疗效。方法：对２６０例（２７９眼）行青光眼白内障联合手术的病例作回顾性分析,并将病人分为３组。Ⅰ组：白内障囊外摘除联合小梁切除术;Ⅱ组：白内障囊外摘除、人工晶体植入联合小梁切除术;Ⅲ组：超声乳化白内障吸出、人工晶体植入联合小梁切除术;并分析比较３组的术后视力、眼压和并发症。结果：３组病例术后视力≥０．３者分别为１６．３％、３２．４％和４３．５％,术后视力改善率分     

Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy

Background To compare endoscopic infrared laser trabecular ablation and trabeculectomy (both combined with cataract surgery) regarding intraocular pressure (IOP), visual acuity, antiglaucomatous drugs and complications.Methods Seventeen eyes of 14 patients [age 74.7±11.7 years (arithmetic mean ± standard deviation)]—13 with primary open-angle glaucoma (POAG) and four with pseudoexfoliation glaucoma (PEXG)—underwent standard cataract surgery. After lens implantation, a probe (1.1 mm external diameter) with optic and laser fibres and an irrigation tube was introduced through the cataract incision. To perforate Schlemms canal, 15–17 single pulses (16 mJ, 160 s) were applied using a photoablative infrared laser (Er:YAG, =2.94 m). All eyes except one received antiglaucoma treatment. The control group treated with cataract surgery and trabeculectomy consisted of 17 eyes (13 POAG, four PEXG) of 15 patients (age 75.0±5.6 years), each eye received antiglaucoma treatment.Results Mean follow-up was 3 years. The eyes treated with the endoscopic laser showed a mean preoperative IOP of 23.3±4.3 mmHg, which was reduced to 15.0±2.1 mmHg (mean IOP lowering 33.7%) after 3 years. Five eyes needed no medication for IOP-control after the procedure. Two eyes needed further surgery for IOP-control. In the control group, mean IOP was 24.5±2.6 mmHg in the beginning and 17.3±6.2 mmHg after 3 years, corresponding to a 33.3% lowering of IOP. Six eyes needed no medication, four eyes needed further surgery to lower IOP.Conclusions After 3 years follow-up of a small pilot group, combined endoscopic infrared laser surgery with cataract surgery seems to be a safe and effective way to lower IOP. It shows the same ability to lower IOP as combined cataract surgery with trabeculectomy. In addition, there are markedly less complications with the endoscope-controlled photoablative laser procedure.The authors have no proprietary interest in the techniques used. This study was presented in part at the 101st meeting of the Deutsche Ophthalmologische Gesellschaft (DOG), Berlin, 2003.     

Phacotrabeculectomy versus two-stage operation: a matched study

BACKGROUND AND OBJECTIVE: To evaluate the efficacy and safety of phacoemulsification and foldable intraocular lens, combined with trabeculectomy (phacotrabeculectomy) in patients with coexisting cataract and glaucoma. PATIENTS AND METHODS: A total of 53 consecutive eyes which underwent phacotrabeculectomy and posterior chamber intraocular lens (PCIOL) were matched and compared with 53 eyes that had trabeculectomy followed by phacoemulsification and posterior chamber intraocular lens (mean interval 3.2 month). The 2 groups were first matched by diagnostic group and subsequently for the closest possible match with other successive variables, including age, gender, race and preoperative glaucoma medications. Mean intraocular pressure (IOP) reduction, visual acuity, antiglaucoma medications, and surgical success as well as complications were compared in both groups. RESULTS: Mean IOP reduction was 14.5+/-4.1 mmHg in the two-stage group compared to 15.1+/-3.9 in the phacotrabeculectomy group at 6 months follow-up (P<0.1) and 13.8+/-3.9 and 14.6+/-3.7 respectively at 1 year (P<0.1).Visual acuity and complications were comparable. CONCLUSION: Phacotrabeculectomy provides IOP control statistically comparable to two-stage surgery with earlier visual rehabilitation.     

Nonpenetrating deep sclerectomy: a 6-year retrospective study

PURPOSE: Nonpenetrating trabeculectomy, also called nonpenetrating deep sclerectomy (NPDS), is a filtering surgery where the internal wall of Schlemm's canal is excised, allowing subconjunctival filtration without actually entering the anterior chamber. This, technique was developed to minimize the complications of trabeculectomy. The authors investigated its safety and efficacy in a retrospective noncomparative study. METHODS: A total of 258 eyes (179 patients, mean age 61.4 +/- 11.56 years) with uncontrolled open angle glaucoma with prior medical therapy were treated. NPDS with a biocompatible collagen device (157 eyes) sutured to deep scleral bed or with the use of a 5-fluorouracil sponge (90 eyes) were analyzed. The main outcome measure was postoperative intraocular pressure (IOP) with an average follow-up of 54.4 +/- 17.07 months (range 1-85). Efficacy was determined 1 month, 3 months, and every 6 months after the procedure for 6 years. RESULTS: Mean preoperative IOP was 24.47 +/- 5.92 mmHg. Mean postoperative IOP was 14.44 +/- 5.31 mmHg (average lowering of the IOP was 38.94 +/- 23.81%) at 1 month, 15.16 +/- 4.57 mmHg (35.73 +/- 21.35%) at 3 months, 15.87 +/- 4.24 mmHg (32.45 +/- 20.52%) at 6 months, 16.32 +/- 4.53 mmHg (29.96 +/- 23.69%) at 12 months, 17.12 +/- 4.45 mmHg (26.51 +/- 23.93%) at 18 months, 16.77 +/- 4.44 mmHg (28.18 +/- 21.73%) at 24 months, 16.43 +/- 4.15 mmHg (28.89 +/- 23.69%) at 30 months, 16.34 +/- 4.12 mmHg (30.05 +/- 21.61%) at 36 months, 16.16 +/- 4.01 mmHg (30.06 +/- 22.55%) at 42 months, 15.71 +/- 3.74 mmHg (32.49 +/- 19.08%) at 48 months, 15.61 +/- 3.48 mmHg (31.26 +/- 21.01%) after 5 years, and 15.81 +/- 3.79 mmHg (33.73 +/- 20.9%) after 6 years. YAG goniopuncture was performed in 47.3% of cases with a mean follow-up of 12 +/- 13 months. These goniopunctures were effective in lowering IOP after a long-term follow-up (24 months). Additional 5-fluorouracil injections were used in 7% of cases. Visual field (Octopus or Humphrey mean defect and corrected loss variance or loss variance) was not modified (p < 0.01). Number of preoperative glaucoma medications was 2.01 +/- 0.58 and number of postoperative glaucoma medications was 0.85 +/- 0.92. Complications were peroperative microperforations in 27 eyes (10.5%), shallow anterior chamber in 2 eyes, hyphema in 2 eyes (0.8%), cataract in 5 eyes (2%), and dellen in 1 eye (0.4%). No cases of endophthalmitis or choroidal detachment were found. After surgery, 23 eyes (8.9%) required a new filtering surgical procedure, and diode laser cyclophotocoagulation was necessary in 2 eyes (0.8%). The probability success rate, defined as an IOP lower than 21 mmHg, was 66.46% (Kaplan Meier) at 60 months off all glaucoma medications and 80.32% with medical or new surgical treatment. CONCLUSIONS: NPDS appears to be an effective and safe filtering procedure for lowering IOP and could be an alternative to trabeculectomy in open angle glaucoma with the advantage of having fewer complications.     

Long-term results of cataract surgery combined with trabeculotomy

BACKGROUND: There are different surgical approaches for cataract and concomitant primary open-angle glaucoma (POAG). In a retrospective study we examined the long-term results of cataract extraction combined with trabeculotomy. PATIENTS AND METHODS: Between 1990 and 1997, 194 eyes with cataract and POAG were operated on in a combined manner. Eighty-eight eyes received a trabeculotomy (TT), in 82 eyes a trabeculectomy was added to the trabeculotomy (TT+TE) and in 24 eyes, in which probing of Schlemm's canal was impossible, standard trabeculectomy (TE) was performed. Pre- and postoperative intraocular pressure (IOP), glaucoma medication, and the intra- and postoperative complications of all patients were analyzed. RESULTS: Hyphema was the most common complication in the TT group (20.5%). Fibrin reaction occurred in 27.8% of all cases. There was no statistically significant difference in postoperative IOP between the TT group and the TT+TE group. A statistically significant decrease in IOP compared to preoperatively lasted 60 months in the TT group. In eyes with a preoperative IOP < or = 20 mmHg, none of the three procedures reduced IOP significantly (<20% of the preoperative IOP). In the first 2 years after operation 50% of the patients had no need for antiglaucomatous medication. CONCLUSIONS: Cataract surgery combined with TT resulted in few complications. In low-tension glaucoma the combination with TT is not sufficient to decrease the IOP. In patients with higher preoperative IOP, however, cataract surgery combined with TT could be--on the basis of a postoperative observation time of 72 months--a suitable method for lowering the IOP sufficiently. Furthermore, the use of antiglaucomatous substances was reduced by this combined procedure.     

Deep sclerectomy with collagen implant: initial experience

OBJECTIVE: To evaluate complications of deep sclerectomy with collagen implant (DSCI), a recently introduced nonpenetrating glaucoma-filtering surgical technique. PATIENTS AND METHODS: 30 eyes of 23 patients with open-angle glaucoma were included in this prospective, noncomparative, interventional case series. In all eyes, preoperative intraocular pressure (IOP) was lowered inadequately by topical antiglaucomatous medications. After undergoing DSCI, the patients were followed prospectively. If necessary, the procedure was combined with cataract surgery or mitomycin C application. RESULTS: In 27 (90%) of 30 eyes, DSCI could be performed. In 3 (10%) of 30 eyes, DSCI had to be transformed intraoperatively into a trabeculectomy because of a large trabecular penetration. Microperforations without further consequences occurred in 2 (7%) of 30 eyes. The mean follow-up was 6.6 +/- 3.8 months. IOP dropped from 26.0 +/- 6.7 to 13.6 +/- 4.7 mm Hg (p < 0.05). Medical glaucomatous treatment was reduced from 2.3 +/- 3.8 to 0.3 +/- 0.6 (p < 0.05). In cases without cataract, visual acuity decreased from 0.7 +/- 0.3 to 0.66 +/- 0.4 at the last visit (p > 0.1). Postoperative complications included Seidel (1/27, 4%), encapsulated bleb (4/27, 15%), astigmatism (1/27, 4%), iris capture (2/27, 7%), microhyphema (3/27, 11%) and peripheral anterior synechiae (4/27, 15%). Fifteen (56%) of the 27 eyes needed the following postoperative procedures: laser goniopuncture (8/27, 30%), needling of the filtering bleb (4/27, 15%), surgical revision in the operating theater (3/27, 11%). All 3 eyes where trabeculectomy was performed instead of DSCI had a favorable course. CONCLUSIONS: During the evaluation period, complications occurred in about half of the cases. None of the complications was severe or irreversible. Target pressure and a reduction in drug treatment could be achieved in all of the patients.     

Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery

PURPOSE: To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery. PATIENTS AND METHODS: All patients of glaucoma with aphakia or pseudophakia who underwent trabeculectomy with or without MMC from January 1989 to April 2000 were included. The medical records of 19 consecutive patients (23 eyes) were reviewed. Data collected from a retrospective chart review were analysed. Outcome measures were evaluated using Kaplan-Meier survival analysis. Pre- and postoperative intraocular pressures (IOPs), visual acuities, success rate, bleb characteristics, surgical failure and complications were the main outcome measures. Successful IOP control was defined as an IOP between 6 and 21 mmHg, without antiglaucoma medications, without further antiglaucoma surgery and without any sight-threatening complication. RESULTS: The mean age of patients was 8.8+/-5.5 years at the time of trabeculectomy with MMC compared to 11.0+/-12.4 years for trabeculectomy without MMC. Eight patients underwent trabeculectomy with MMC and 11 patients underwent trabeculectomy without MMC. There was no statistically significant difference between the two groups in terms of visual acuity, IOP, antiglaucoma medications, age at cataract surgery and at trabeculectomy. The IOP reduced from a preoperative level of 34.2+/-8.9 mmHg (range: 20-52) to a postoperative level of 18.4+/-12.2 mmHg (range: 2-60) with a mean follow-up of 24.2+/-17.9 months. The mean reduction in IOP in the MMC group was 15.5+/-17.3 and 16.3+/-13.8 mmHg in the other group (P = 0.967). Overall, complete success was achieved in 36.8%, qualified success in 21.1% and surgical failure in 42.1% of patients with a mean follow-up of 24.2+/-17.9 months. There was no difference in the success between the two groups at the last follow-up. One patient developed bleb-related endophthalmitis in both eyes following trabeculectomy with MMC. CONCLUSIONS: The success rate of trabeculectomy in glaucoma following congenital cataract surgery was 36.8% at the end of 3 years. The present study proves a poor success rate of trabeculectomy in a small series of aphakic Asian Indian patients even with the use of MMC.     

Intermediate-term comparison of trabeculectomy with intraoperative mitomycin-C between Asian American and Caucasian glaucoma patients: a case-controlled comparison

PURPOSE: Compare the efficacy and survival of trabeculectomy with intraoperative mitomycin-C (MMC) between Asian American and Caucasian patients in the same clinical setting. METHODS: In total, 29 Asian American patients (29 eyes) with trabeculectomies were matched case to case with 29 Caucasian patients (29 eyes) retrospectively. Matching criteria included age, glaucoma subtype, and preoperative intraocular pressure (IOP), gender, surgeon, ocular history, and glaucoma medications. Criteria of success included: (1) Final IOP>5 and <22 mmHg, (2) IOP reduction>or=20%, or final IOP相似文献   

Trabeculectomy combined with phacoemulsification and intraocular lens implantation

It has recently become popular to use mitomycin C (MMC) with trabeculectomy. MMC helps to maintain effective filtration and long-term intraocular pressure (IOP) control, while the use of laser suture lysis has improved the safety of this procedure. We evaluated the outcome of trabeculectomy alone and of trabeculectomy plus phacoemulsification (PEA) and intraocular lens (IOL) implantation, each supplemented with MMC. The mean preoperative IOP for the trabeculectomy alone group was 22.4 +/- 3.2 mmHg(bleb+), 25.3 +/- 2.6 mmHg(bleb-), and that of the combined surgery group was 22.4 +/- 2.8 mmHg(bleb+), 21.0 +/- 3.5 mmHg(bleb-). Mean postoperative IOP for the two groups were 13.3 +/- 2.7 mmHg(bleb+), 17.1 +/- 4.4 mmHg(bleb-) and 11.9 +/- 2.7 mmHg(bleb+), 16.4 +/- 3.4 mmHg(bleb-), respectively. After 4.5 years, the success probability for postoperative IOP control was 38%(bleb+), 3%(bleb-) in the trabeculectomy alone group and 53%(bleb+), 10%(bleb-) in the combined surgery group (相似文献   

不同手术方法治疗闭角型青光眼合并短眼轴的对比观察

目的:比较单纯小梁切除术和小梁切除术联合白内障超声乳化联合人工晶状体植入术(以下简称三联术)治疗闭角型青光眼合并短眼轴的疗效。方法:回顾分析2005-07/2009-01收住我院的闭角型青光眼合并短眼轴患者31例39眼。行单纯小梁切除术者25眼,行三联术者14眼。术后随访1～25(平均9.51±6.11)mo。结果:术后眼压:三联术者术后眼压平均(11.31±0.69)mmHg,手术前后有显著统计学差异(P<0.01);小梁切除术者术后平均(18.47±3.54)mmHg,手术前后差异有统计学意义(P<0.05);最佳矫正视力:三联术者术后均提高,≥0.3者占78%,小梁切除术者术后5眼视力不增反降,≥0.3者占32%,两者差异有显著性;UBM(超生生物显微镜)检查:小梁虹膜角(TIA)三联术者手术前后差异有显著性,小梁切除术者手术前后无显著性差异;中央前房深度(ACD):三联术术后平均为(3.22±0.53)mm,手术前后有显著性差异(P<0.01),小梁切除术后平均为(2.21±0.41)mm,比较差异无显著性;术后并发症:三联术术后并发症少,且均无需再手术纠正,小梁切除术者术后并发症较多,部分严重且持久,需再次手术。结论:小梁切除术联合白内障超声乳化联合人工晶状体植入术治疗闭角型青光眼合并短眼轴较单纯小梁切除术设计更合理,手术成功率高,疗效好,并发症少。     

Postoperative intraocular pressure rise in open-angle glaucoma patients after cataract or combined cataract-filtration surgery

Postoperative intraocular pressure (IOP) was measured in patients with open-angle glaucoma undergoing extracapsular cataract extraction with a posterior chamber lens implant (ECCE-PC IOL). Patients considered to be under adequate medical glaucoma control had cataract surgery alone or combined with a posterior lip sclerectomy. Patients with medically uncontrolled glaucoma had cataract surgery combined with either a posterior lip sclerectomy or a trabeculectomy. Cataract surgery alone (n = 26) was associated with a significantly (P less than 0.001) increased IOP on postoperative day 1: preoperative IOP, 18.9 +/- 3.6 mmHg; postoperative IOP, 34.2 +/- 12 mmHg. An IOP rise of 10 mmHg or more occurred in 69% of the eyes, whereas 77% of the eyes had an absolute IOP over 25 mmHg. Eyes undergoing combined surgery (n = 42) had a preoperative IOP of 21.3 +/- 4.8 mmHg. On postoperative day 1, the mean IOP was 14.9 +/- 12.0 mmHg. An IOP rise of 10 mmHg or more was observed in 14%, and an IOP over 25 mmHg in 21% of combined surgery eyes. Cataract surgery in eyes with open-angle glaucoma requires careful monitoring and therapy for early postoperative increases in IOP. Combined surgery reduces the frequency and magnitude of, but does not eliminate, this complication.     

Microendoscopic trabecular surgery in glaucoma management

OBJECTIVE: To evaluate the safety and efficacy of trabecular surgery under microendoscopic control in the management of advanced chronic open-angle glaucoma when the presence of corneal opacification obscures adequate visualization of the anterior segment. STUDY DESIGN: Comparative interventional case series. PARTICIPANTS AND INTERVENTION: Fifteen eyes of 15 patients with medically uncontrolled open-angle glaucoma and moderate-to-severe corneal opacification underwent trabecular surgery under microendoscopic control. Seven eyes were treated by photoablative laser goniopuncture and eight eyes by goniocurettage. MAIN OUTCOME MEASURES: The intraocular pressure (IOP) and number of medications before and after surgery were measured. Intraoperative and postoperative complications were analyzed. RESULTS: The ophthalmic microendoscope was successfully used in visualizing and identifying the anterior chamber angle structures and in controlling the trabecular surgical procedures in all eyes. The IOP dropped from 34.5 +/- 6.9 millimeters of mercury (mmHg) (range, 27-46 mmHg) under maximal-tolerated medical therapy before surgery to 18.5 +/- 3.0 mmHg (range, 15-23 mmHg) at 21 months after surgery. Medication averaged 2.3 +/- 0.6 before surgery and dropped to 1.0 +/- 0.7 at last follow-up. No difference was observed in the surgical outcome between the laser-treated eyes and those receiving goniocurettage. No severe intraoperative or postoperative complications relating to either the trabecular surgery or to the use of the microendoscope were observed. CONCLUSION: The ophthalmic microendoscope appears to be safe and effective in simultaneously providing illumination, video recording, and clear endoscopic view of the fine details of the anterior chamber angle structures. Microendoscopy enables various trabecular surgical procedures, such as goniocurettage or photoablative laser goniopuncture, which can be performed in the presence of corneal opacification that might otherwise preclude adequate visualization and treatment. It thus appears that microendoscopic trabecular surgery may in the future be considered as an alternative choice of surgical treatment in some cases of open-angle glaucoma.     

青光眼术后硬核白内障改良小切口囊外摘出术

目的:观察青光眼小梁切除术后硬核白内障行改良小切口囊外摘出及人工晶状体植入术的临床疗效。方法:对65例(69眼)小梁切除术后硬核(Ⅳ/Ⅴ)白内障,行颞侧或颞上方小切口白内障囊外摘出人工晶状体植入术,术后随访6~24mo,观察术后视力、眼压和并发症。结果:本组65例(69眼)术后视力有不同程度提高,其中视力≥0.5者50眼(72%),术后平均眼压为(15.22±3.92)mmHg(1mmHg=0.133kPa),手术并发症为术后早期角膜水肿及葡萄膜炎性反应。结论:青光眼小梁切除术后硬核白内障行改良小切口囊外摘出及人工晶状体植入术操作简单,术后眼压控制好,并发症少,视力恢复快,是治疗青光眼术后硬核白内障的有效方法。     

Mini-trabeculectomy in comparison to conventional trabeculectomy in primary open angle glaucoma

PURPOSE: To evaluate the safety and efficacy of mini-trabeculectomy in comparison to conventional trabeculectomy in primary open angle glaucoma (POAG). METHODS: A prospective interventional study of mini-trabeculectomy versus conventional trabeculectomy was undertaken on 60 eyes of 54 medically uncontrolled POAG patients requiring glaucoma surgery. They were divided into two groups: Group I underwent mini-trabeculectomy (30 eyes of 26 patients) and Group II underwent conventional trabeculectomy (30 eyes of 28 patients). All patients were followed up for at least 15 months. Statistical analysis was carried using Student's t test and paired t test for quantitative data and Pearson's chi-square test for qualitative data. RESULTS: The mean intraocular pressures (IOP) at the end of 15 months of follow-up in Groups I and II were 15.80+/-4.3 mmHg and 16.13+/-3.3 mmHg versus mean preoperative IOP of 28.63+/-2.74 and 28.60+/-2.44, p<0.0001, respectively. The difference in IOP control was significant only at 6 months of follow up (13.65+/-3.45 versus 15.98+/-4.05, p=0.041). The complications and failure were comparatively less in Group I. CONCLUSIONS: Mini-trabeculectomy is a safe and effective alternative to conventional trabeculectomy in terms of IOP control. A modified tunnel incision employed in mini-trabeculectomy may be responsible for avoiding some of the complications.     

Nd:YAG激光房角穿刺治疗非穿透性小梁手术后高眼压

目的观察评估Nd:YAG激光行房角穿刺治疗非穿透性小梁手术后眼压控制不理想的原发性开角型青光眼患者的临床疗效。方法选取非穿透性小梁手术后眼压控制不理想(不用降眼压药物眼压>21mmHg,1kPa=7.5mmHg)的原发性开角型青光眼患者35例(38眼)为研究对象,硝酸毛果芸香碱缩瞳后,在激光房角镜下原手术部位行Nd:YAG激光房角穿刺,观察激光前及激光后1h、1d、1周、1个月、3个月、6个月、12个月、18个月、2a时的眼压、滤过泡、房角及前房反应情况。结果激光前及激光后1h、1d、1周、1个月、3个月、6个月、12个月、18个月、2a的眼压分别为(25.0±3.4)mmHg、(12.5±3.4)mm-Hg、(12.0±3.2)mmHg、(13.1±3.0)mmHg、(14.0±3.1)mmHg、(14.1±2.7)mmHg、(14.3±2.9)mmHg、(15.3±2.6)mmHg、(16.2±2.8)mmHg、(16.0±3.0)mmHg,激光后各时间点眼压均较激光前下降,差异均有统计学意义(均为P<0.01)。其中10眼激光后眼压、滤过泡无明显改善,28眼滤过泡形成或原滤过泡面积、隆起度增大;激光后发生浅前房2眼(5.3%),虹膜周边前粘连2眼(5.3%),无前房出血、脉络膜脱离等并发症发生。结论 Nd:YAG激光房角穿刺能够安全有效地改善非穿透性小梁手术后小梁网-狄氏膜的房水低滤过状态,是非穿透性小梁手术后高眼压治疗的有效方法。     

Phacoemulsification in trabeculectomized eyes

PURPOSE: To evaluate retrospectively risk indicators for cataract surgery and the effect of phacoemulsification on intraocular pressure (IOP) control in eyes that have undergone trabeculectomy. METHODS: We undertook a retrospective analysis of 138 eyes with primary open-angle glaucoma (POAG) or exfoliation glaucoma (EG) in 138 consecutive patients over the age of 40 years undergoing trabeculectomy with no antimetabolites performed by one surgeon. Of the 48 eyes (35%) undergoing a cataract operation during the follow-up period of 2-5 years, 46 were included in this analysis. Their IOP, glaucoma medication and best corrected visual acuity (BCVA) before cataract surgery and at the last follow-up were compared. Risk indicators for cataract surgery were analysed. RESULTS: Cataract operations were performed 5.1-58.1 months (median 14.4 months) after trabeculectomy. The mean length of follow-up after cataract surgery was 25.3 months (SD 12.9, median 24.8 months). Before cataract surgery, the mean IOP was 16.2 mmHg (SD 4.9) and the mean number of topical antiglaucoma medicines 0.8 (SD 1.0). At the most recent visit, mean IOP was 17.3 mmHg (SD 6.4) (p = 0.35), and the mean number of medicines was 1.3 (SD 1.1) (p = 0.0007). Of the 22 eyes in which treatment had been categorized as completely successful (IOP < or = 21 mmHg without other therapy) before cataract surgery, 13 (59%) had remained so. The number of failures (IOP > 21 mmHg, or more than one medication needed or further surgery performed) increased from 14 (30%) before surgery to 28 (61%) afterwards. The proportion of failures in the cataract surgery group was twice that in the no cataract surgery group (61% versus 31%). In a proportional hazards regression, only age (73.9 years [SD 9.4] and 68.1 years [SD 9.8] in patients with and without cataract surgery, respectively) proved to be a significant (p = 0.001) indicator for surgery. CONCLUSION: The results of this retrospective study on consecutive clinical cases of trabeculectomy indicate that cataract progression after trabeculectomy is mainly an age-related process. In more than half the eyes with good preoperative IOP control, this good control was maintained after cataract surgery. On the other hand, in some eyes cataract surgery may compromise IOP control even when surgery avoids the area of the bleb.